Lazard Asset Management’s Biote BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$63.8K Hold
52,753
– – ﹤0.01% 1862
2026
Q2
$100K Buy
52,753
+3,810
+8% +$7.85K ﹤0.01% 1755
2026
Q1
$66.1K Buy
48,943
+37,270
+319% +$74.9K ﹤0.01% 1766
2025
Q4
$30.4K Sell
11,673
-312
-3% -$853 ﹤0.01% 1815
2025
Q3
$36K Sell
11,985
-3,891
-25% -$13.9K ﹤0.01% 1752
2025
Q2
$63K Sell
15,876
-5,073
-24% -$18.7K ﹤0.01% 1965
2025
Q1
$69K Sell
20,949
-1,652
-7% -$7.88K ﹤0.01% 1917
2024
Q4
$139K Buy
+22,601
New +$131K ﹤0.01% 1714

Other funds holding BTMD

Lazard Asset Management's BTMD Position: Q3 2026 in Review

Lazard Asset Management held its Biote (BTMD) position steady in Q3 2026 at 52,753 shares worth $63.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1862.

Lazard Asset Management first reported a position in BTMD in Q4 2024 and has held it in 8 quarters since. The position peaked at $139K in Q4 2024. 57 funds tracked by Wall St. Rank hold BTMD as of Q3 2026.

  • Lazard Asset Management held 52,753 shares of Biote worth $63.8K as of Q3 2026.
  • Lazard Asset Management left its Biote share count unchanged in Q3 2026.
  • Biote made up ﹤0.01% of Lazard Asset Management's portfolio in Q3 2026, its #1862 holding.
  • Lazard Asset Management first reported a position in Biote in Q4 2024 and has held it in 8 quarters since.
  • Lazard Asset Management's Biote position peaked at $139K in Q4 2024.
  • 57 funds tracked by Wall St. Rank held Biote as of Q3 2026.

Based on Lazard Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.